Patent ID: 11944612
Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. A capsule dosage form comprising:
(i) from about 65% to about 86% w/w of Compound 1;, (ii) from about 2% to about 6% w/w a binder;
(iii) from about 6% to about 25% w/w a filler;
(iv) from about 2% to 6% w/w a disintegrant; and
(iv) from about 0.5% to about 1.5% w/w a lubricant;
wherein w/w is relative to the total weight of the formulation, excluding the weight of the capsule; and
wherein the compound 1 is in a crystalline ansolvate form that is characterized by at least four X-ray powder diffraction peaks (Cu Kα radiation) at 13.37°, 14.37°, 19.95° and 23.92° 2θ, each peak is ±0.2° 2θ.